Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Oct 27;74(8):1192-4.
doi: 10.1097/00007890-200210270-00025.

All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

Po-Chang Lee  1 , Paul I Terasaki, Steven K Takemoto, Po-Huang Lee, Chung-Jye Hung, Yi-Lin Chen, Alen Tsai, Huan-Yao Lei
Affiliations

All chronic rejection failures of kidney transplants were preceded by the development of HLA antibodies

Po-Chang Lee et al. Transplantation. .

Abstract

Background: Recent studies show that almost all patients who have rejected a kidney transplant had human leukocyte antigen (HLA) antibodies. In this study, we sought to determine whether patients develop HLA antibodies before chronic rejection.

Methods: For the past 8 years, 139 patients who had undergone kidney transplantation were systematically examined, using an enzyme-linked immunosorbent assay-based method, for the development of class-I and class-II HLA antibodies 3 months, 6 months, and yearly after transplantation. Chronic rejection was diagnosed by biopsy.

Results: Among 29 patients with chronic rejection, 100% of the patients had HLA antibodies before rejection. Of these patients, 14 patients developed antibodies de novo. In contrast, among 110 patients with stable function, 27% of the patients developed HLA antibodies posttransplant (P<0.001).

Conclusions: HLA antibodies were found in 29 consecutive cases of chronic rejection failures as much as one year before the loss of grafts. We conclude that HLA antibodies may be a prerequisite for chronic immunologic rejection.

PubMed Disclaimer

Comment in